TAIWAN · TWSE / TPEx
Pharmigene
世基生醫 · 7595 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$7.251 month +3.0% · 1 year -39.1%
Directors and supervisors hold15,508,62630.7% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold9,544,10018.9% of shares issued
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 台灣沁月股份有限公司 | Chairman · Director | 4,956,526 | 4,956,526 | 9.82% | — | — |
| 蔡詩辰 | Chairman (corporate representative) | — | 480,000 | 0.95% | — | — |
| 詹富蕙 | Director (corporate representative) | — | 953,000 | 1.89% | — | 1,702,291 |
| 邱致閔 | Director (corporate representative) | — | 1,190,500 | 2.36% | — | — |
| 陳冠志 | Director | 108,000 | 108,000 | 0.21% | — | — |
| 李俊逸 | Director | 900,000 | 900,000 | 1.78% | — | — |
| 來瑪科技股份有限公司 | Director · Major shareholder (10%+) | 9,544,100 | 9,544,100 | 18.91% | — | — |
| 徐英洲 | Director (corporate representative) · President | — | 0 | — | — | — |
| 張承能 | Director (corporate representative) | — | 0 | — | — | — |
| 陳奕雄 | Independent director | — | 0 | — | — | — |
| 陳持平 | Independent director | — | 0 | — | — | — |
| 陳憶柔 | Independent director | — | 0 | — | — | — |
| 施克和 | Independent director | — | 0 | — | — | — |
| 蔡文婷 | Vice president | — | 106,000 | 0.21% | — | — |
| 林心郁 | Vice president | — | 150,000 | 0.30% | — | — |
| 章人勻 | Vice president | — | 3,176 | 0.01% | — | — |
| 邱怡宣 | Assistant vice president | — | 1,733 | 0.00% | — | 3,000 |
| 傅秀英 | Assistant vice president | — | 0 | — | — | — |
| 楊少東 | Chief accountant | — | 0 | — | — | — |